Mounjaro Cost (2026): Why It’s Pricier Than Zepbound

Affiliate disclosure: This article contains affiliate links. We may earn commission when you purchase through partner links, at no extra cost to you. Editorial independence preserved — recommendations based on provider compliance and patient outcomes, not commission rates. This article is informational and is not medical advice.

Ask what Mounjaro costs and you will get answers ranging from $25 a month to well over $1,000. Both can be true. Mounjaro is tirzepatide, made by Eli Lilly, and it is FDA-approved for one thing: type 2 diabetes. That single fact — the reason you were prescribed it — shapes your cost more than the pharmacy you use or any coupon you find. This guide breaks down what Mounjaro actually costs in 2026, and why the gap between the cheapest and most expensive ways to get it is so wide.

The List Price — and Why It’s Rarely the Real Price

Mounjaro’s manufacturer list price is about $1,080 a month for a 28-day supply — four prefilled pens, one weekly injection each. At retail pharmacies, the cash price without insurance typically lands between roughly $1,000 and $1,200, and it is much the same across dose strengths.

A pharmacy discount card such as GoodRx or SingleCare can trim that, usually to somewhere in the $900s — a real but modest reduction. As with every brand-name GLP-1, though, the list price is mostly a worst case. Whether you pay anywhere near it depends entirely on the question in the next section.

The Question That Decides Your Cost — Diabetes or Weight Loss?

Mounjaro is approved by the FDA to treat type 2 diabetes — and only that. It is not approved for weight loss. The tirzepatide product approved for weight management is Zepbound: the identical active drug, at the same doses, under a different name.

Many people are nonetheless prescribed Mounjaro off-label for weight loss, which is both legal and common. But it matters enormously for cost, because insurance plans and manufacturer savings programs are built around a drug’s approved use. Whether you are taking Mounjaro for type 2 diabetes — the reason it exists — or off-label for weight loss determines almost everything about what you will pay. The two cases are worth separating.

Paying for Mounjaro With Type 2 Diabetes

If you have type 2 diabetes, Mounjaro is being used as approved, and that opens up affordability routes — though, as the list below shows, most of them depend on the coverage you already have.

• Commercial insurance. Most commercial and employer plans cover Mounjaro for type 2 diabetes, generally with prior authorization. Your cost then becomes a plan-set copay.
• The Mounjaro Savings Card. For patients with commercial insurance that covers Mounjaro, the savings card can bring the copay down to as little as $25 a month. If you have commercial insurance that does not cover Mounjaro, a second savings-card tier still applies, with a higher floor of around $499 a fill. The card cannot be used with Medicare, Medicaid or Tricare.
• Medicare Part D. Most Part D plans cover Mounjaro for type 2 diabetes, typically with prior authorization; the copay varies by plan.
• Patient assistance. Lilly’s patient assistance program, Lilly Cares, can provide Mounjaro at no cost to qualifying uninsured patients with low household income — and, unlike some manufacturer assistance programs, it does cover Mounjaro for diabetes.

For an insured person with type 2 diabetes, in other words, Mounjaro is frequently a $25-a-month medication, and for low-income uninsured patients it can be free. The list price rarely tells that story. The harder case is the uninsured diabetes patient whose income sits above the Lilly Cares threshold: with no insurance for the savings card to work against, and no manufacturer self-pay program for Mounjaro, that patient is realistically left with a discount-card price in the $900s or the list price itself.

Paying for Mounjaro for Weight Loss — and Why Zepbound Usually Wins

If you do not have diabetes and want Mounjaro for weight loss, the cost picture turns sharply less friendly — and there is an important wrinkle specific to Mounjaro.

Because weight-loss use is off-label, insurance plans generally will not cover it, and the savings card is tied to covered, on-label prescriptions. So far, this mirrors any off-label GLP-1. But Mounjaro has a further disadvantage. Eli Lilly’s discounted direct-to-patient self-pay program — the one that sells single-dose tirzepatide vials at $299 to $449 a month — applies to Zepbound, not Mounjaro. There is no equivalent low-cost self-pay program for Mounjaro, because Lilly built that program for the cash-paying weight-loss market and pointed it at the weight-loss brand. The federal TrumpRx portal, launched in early 2026, follows the same pattern — its discounted tirzepatide is offered as Zepbound, at around $299 a month. An uninsured person paying cash for Mounjaro is therefore looking at roughly $1,000 a month, or a discount-card price in the $900s.

This leads to a straightforward conclusion. If your goal is weight loss, Zepbound — the same tirzepatide, approved for exactly that purpose — is both the on-label choice and, through its self-pay vials, far the cheaper one. Paying cash for off-label Mounjaro for weight loss is, in 2026, close to the worst-value way to take tirzepatide. Our Zepbound cost guide covers that route in full.

A cheaper route still is compounded tirzepatide — the same active drug prepared by compounding pharmacies, typically priced below brand. It is not an FDA-approved product, and its quality depends on the compounding pharmacy rather than on FDA review.

Frequently Asked Questions

How much does Mounjaro cost without insurance in 2026?

The manufacturer list price is about $1,080 a month, and retail cash prices typically run between roughly $1,000 and $1,200. A GoodRx or SingleCare discount card can lower that into the $900s. Unlike Zepbound, Mounjaro has no discounted manufacturer self-pay program, so uninsured patients have fewer ways to get below the retail figure.

Why is Mounjaro cheaper for diabetes than for weight loss?

Because Mounjaro is FDA-approved for type 2 diabetes. Insurance plans and the manufacturer’s savings card are built around a drug’s approved use, so a diabetes patient can often get Mounjaro for a $25 copay — or free through patient assistance. Used off-label for weight loss, those doors largely close.

Can I get the $25 Mounjaro Savings Card price?

Only if you have commercial insurance that covers Mounjaro — then the card can lower the copay to as little as $25 a month. Commercially insured patients whose plan does not cover Mounjaro fall into a second tier with a higher floor, around $499 a fill. Uninsured patients and those on Medicare, Medicaid or Tricare cannot use the card at all.

Does LillyDirect sell Mounjaro cheaply like Zepbound?

No. Eli Lilly’s discounted self-pay vials — single-dose tirzepatide at $299 to $449 a month — are part of the Zepbound Self Pay Journey Program. There is no equivalent low-cost self-pay program for Mounjaro. For tirzepatide at a lower cash price, that route runs through Zepbound, not Mounjaro.

Does Medicare cover Mounjaro?

Yes — most Medicare Part D plans cover Mounjaro for type 2 diabetes, usually with prior authorization, with the copay set by your plan. Note that Mounjaro is not part of the Medicare GLP-1 Bridge, the new program covering weight-loss drugs, because Mounjaro is approved for diabetes rather than for weight management.

The Bottom Line

Mounjaro’s roughly $1,080 list price is the figure that frightens people and the one almost no diabetes patient actually pays. With type 2 diabetes, Mounjaro is used as approved: commercial insurance and Medicare cover it, the savings card can mean $25 a month, and Lilly Cares can make it free for low-income uninsured patients. For weight loss, the drug is off-label, the coverage and savings doors close, and — unlike Zepbound — Mounjaro has no discounted self-pay program to fall back on.

That last point is the practical heart of it: if weight loss is your goal, Zepbound is the same tirzepatide, approved for the purpose, and the cheaper way to pay. Be clear with your prescriber about why you are taking tirzepatide, and match the brand and the payment route to that answer. For the wider picture across every GLP-1, see our full GLP-1 cost guide, and our Ozempic cost guide for the semaglutide equivalent of this same diabetes-versus-weight-loss split.

This article is general information, not medical or financial advice. Prices and programs reflect the situation as of May 2026 and change frequently; confirm current pricing and eligibility with the manufacturer, your insurer or your pharmacy before making decisions.